← Back to news

Markets

Jim Cramer Shows Bullish Sentiment Toward Oscar Health Because of CEO Mark Bertolini

Y

Jim Cramer on Ares Capital: “I Want to Be Very Careful There”

Y

Jim Cramer on Honeywell: “It’s Finally Getting Credit for All the Things It’s Doing”

Y

Jim Cramer on Simon Property’s CEO: “We Think David Simon’s the Best Mall Operator There Is”

Y

Jim Cramer on Crinetics: “That’s a Better Spec Than Aquestive”

Y

Jim Cramer on GE HealthCare: “I Just Don’t Think It’s What You Want to Own”

Y

Jim Cramer Says “Let’s Buy CVS, Not UnitedHealth”

Y

Jim Cramer on Aquestive Therapeutics: “I’m Not Sure If They Deserve the Benefit of the Doubt”

Y

Jim Cramer on FedEx Freight Spin-Off Plans: “This Deserves a Lot of Attention”

Y

Jim Cramer Says “When the Freight Market Turns Around, J.B.Hunt Should Be Able to Make a Fortune”

Y

Jim Cramer on Boeing: “It’s My Favorite Stock in the Charitable Trust”

Y

Jim Cramer Calls Lam Research the “Best of the Best” But Warns Against Buying Parabolic Moves

Y

8 Undervalued Tech Stocks That Could Rip Higher After Q4 Results

I

What Investors Should Know Before Buying Incyte

S

Where And Why For Gold And Silver

S

Is It Too Late for a Roth Conversion? I'm 60 With $930k in My IRA and Have Started Social Security.

Y

Micron Technology: Structural Demand Is Replacing Cyclical Volatility

S

Oklo: Meta Just Turned A Maybe Into A When

S

Ares Capital: A Quality Cash Cow With A 9.3% Yield

S

Australia watchdog orders audit of fintech Airwallex on suspected compliance miss

Y

Housing Market’s Blue Christmas: Pending Sales Slide Most Since 2001

Y

CFP Board Taps K. Dane Snowden as Next CEO

Y

Fanuc Corporation ADR (FANUY) Shares Gain After Earnings Beat and Guidance Upgrade

Y

US stocks climb some more after Trump calls off his tariffs for Greenland

Y

JPMorgan Resumes Coverage of Chevron (CVX) with ‘Overweight’ Rating

Y

ConocoPhillips (COP) Downgraded at JPMorgan

Y

EOG Resources (EOG) Price Target Lowered by $7

Y

HF Sinclair (DINO) Price Target Reduced by $1, ‘Overweight’ Rating Maintained

Y

Exxon Mobil (XOM) Price Target Raised by $9 at JPMorgan

Y

Ovintiv (OVV) Price Target Raised to $54

Y

Analyst Raises Price Target on Phillips 66 (PSX)

Y

Chord Energy (CHRD) Price Target Reduced by $6

Y

Shell Expects Uptick in Upstream Production in Q4 2025

Y

BP Expects Strong Reduction in Net Debt in Q4 2025

Y

Canadian Natural Resources (CNQ) in Talks to Acquire Natural Gas Properties from Tourmaline

Y

Scotiabank Raises CVX Target to $168 in U.S. Integrated Oil and E&P Update

Y

Bernstein Cuts Comcast (CMCSA) Target to $32, Keeps Market Perform Amid Rising Competition

Y

3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade

Y

Bristol-Myers (BMY): UBS Turns Bullish as Biotech and Pharma Show Signs of a Recovery

Y

Crypto Firm BitGo, Backers Raise $212.8 Million in US IPO

Y

Morgan Stanley Raises Target (TGT) to $125, Reaffirms Overweight in Retail Sector Update

Y

Truist Cuts Best Buy (BBY) Target to $73, Keeps Hold Rating After Spending Data Review

Y

Mizuho Raises Prudential (PRU) Target to $126, Keeps Neutral Rating

Y

Franklin Resources (BEN) Target Raised as Barclays Updates Asset Manager Models

Y

Netflix Switches To All-Cash Offer For Warner Bros Discovery Amid Board Support

Y

Barclays Q4 Preview: Kimberly-Clark (KMB) Target Cut, “enthusiasm” Not Driven by Fundamentals

Y

GDX vs. GLDM: Gold Miners With Leverage or Direct Gold Price Exposure

Y

Morgan Stanley Cuts Smucker (SJM) Target After Strong Run, Flags Margin Recovery Risk

Y

This Is One of the Best Nuclear Stocks to Hold for the Next 10 Years

Y

Eastman Chemical (EMN): Citi Raises Target to $75, RBC Downgrades on Limited Growth Catalysts

Y